LIVN – LivaNova PLC
LivaNova PLCLIVN
$90.87Name : LivaNova PLC
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $5,005,462,528.00
EPSttm : 3.49
LivaNova PLC
$90.87
0.30%$0.275
LIVN — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
11.3
Margin Of Safety %
-10
Put/Call OI Ratio
0.22
EPS Next Q Diff
0.03
EPS Last/This Y
0.53
EPS This/Next Y
0.29
Price
91.13
Target Price
108.1
Analyst Recom
1.75
Performance Q
12.82
Upside
-50.4%
Beta
0.9
Ticker: LIVN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | LIVN | 77.26 | 0.48 | 0.00 | 416 |
| 2026-10-13 | LIVN | 76.34 | 0.48 | 0.00 | 416 |
| 2026-10-14 | LIVN | 76.04 | 0.48 | 0.00 | 416 |
| 2026-10-15 | LIVN | 78.55 | 0.48 | 999.99 | 416 |
| 2026-10-16 | LIVN | 77.64 | 0.49 | 1.00 | 420 |
| 2026-10-19 | LIVN | 78.19 | 0.50 | 999.99 | 382 |
| 2026-10-20 | LIVN | 79.72 | 0.50 | 999.99 | 383 |
| 2026-10-21 | LIVN | 78.46 | 0.52 | 0.00 | 388 |
| 2026-10-22 | LIVN | 81.3 | 0.52 | 0.15 | 390 |
| 2026-10-23 | LIVN | 80.87 | 0.49 | 999.99 | 417 |
| 2026-10-26 | LIVN | 80.6 | 0.49 | 0.20 | 418 |
| 2026-10-27 | LIVN | 80.38 | 0.49 | 0.20 | 418 |
| 2026-10-28 | LIVN | 80.65 | 0.49 | 0.93 | 422 |
| 2026-10-29 | LIVN | 81.26 | 0.49 | 0.93 | 422 |
| 2026-10-30 | LIVN | 78.91 | 0.48 | 0.00 | 430 |
| 2026-11-02 | LIVN | 80.24 | 0.47 | 1.25 | 439 |
| 2026-11-03 | LIVN | 80.02 | 0.48 | 1.00 | 447 |
| 2026-11-04 | LIVN | 94.55 | 0.86 | 0.01 | 2056 |
| 2026-11-05 | LIVN | 91.19 | 0.39 | 0.01 | 3486 |
| 2026-11-06 | LIVN | 90.03 | 0.27 | 0.00 | 4658 |
| 2026-11-09 | LIVN | 92.59 | 0.26 | 0.01 | 4691 |
| 2026-11-10 | LIVN | 91.13 | 0.22 | 0.02 | 5464 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | LIVN | 77.29 | -4.6 | 88.1 | 4.36 |
| 2026-10-13 | LIVN | 76.24 | -4.6 | 82.1 | 4.36 |
| 2026-10-14 | LIVN | 76.11 | -4.6 | 84.5 | 4.36 |
| 2026-10-15 | LIVN | 78.55 | -4.6 | 92.1 | 4.36 |
| 2026-10-16 | LIVN | 77.60 | -4.6 | 82.5 | 4.36 |
| 2026-10-19 | LIVN | 78.14 | -4.6 | 87.0 | 4.36 |
| 2026-10-20 | LIVN | 78.14 | -4.6 | 87.0 | 4.36 |
| 2026-10-21 | LIVN | 79.72 | -4.6 | 90.1 | 4.36 |
| 2026-10-22 | LIVN | 81.29 | -4.6 | 94.0 | 4.36 |
| 2026-10-23 | LIVN | 80.90 | -4.6 | 84.1 | 4.36 |
| 2026-10-26 | LIVN | 80.56 | -4.6 | 84.3 | 4.36 |
| 2026-10-27 | LIVN | 80.36 | -4.6 | 84.5 | 4.36 |
| 2026-10-28 | LIVN | 80.68 | -4.6 | 86.2 | 4.36 |
| 2026-10-29 | LIVN | 81.29 | -4.6 | 87.1 | 4.36 |
| 2026-10-30 | LIVN | 78.96 | -4.6 | 78.5 | 4.36 |
| 2026-11-02 | LIVN | 80.21 | -4.6 | 89.0 | 4.36 |
| 2026-11-03 | LIVN | 80.07 | -4.6 | 88.6 | 4.36 |
| 2026-11-04 | LIVN | 94.22 | -4.6 | 127.8 | 4.36 |
| 2026-11-05 | LIVN | 91.20 | -4.6 | 70.3 | 4.36 |
| 2026-11-06 | LIVN | 90.03 | 22.7 | 74.8 | 4.36 |
| 2026-11-09 | LIVN | 92.58 | 22.7 | 84.8 | 4.36 |
| 2026-11-10 | LIVN | 91.13 | 12.8 | 74.1 | 4.43 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | LIVN | -5.49 | 0.72 | 10.94 |
| 2026-10-13 | LIVN | -5.49 | 0.72 | 10.94 |
| 2026-10-14 | LIVN | -5.49 | 0.72 | 10.94 |
| 2026-10-15 | LIVN | -5.49 | 0.72 | 10.94 |
| 2026-10-16 | LIVN | -5.49 | 0.72 | 10.94 |
| 2026-10-19 | LIVN | -5.49 | -0.10 | 10.94 |
| 2026-10-20 | LIVN | -5.49 | -0.10 | 10.94 |
| 2026-10-21 | LIVN | -5.49 | -0.10 | 10.94 |
| 2026-10-22 | LIVN | -5.49 | -0.10 | 10.94 |
| 2026-10-23 | LIVN | -5.49 | -0.10 | 10.94 |
| 2026-10-26 | LIVN | -5.49 | -0.18 | 10.94 |
| 2026-10-27 | LIVN | -5.49 | -0.18 | 11.30 |
| 2026-10-28 | LIVN | -5.49 | -0.18 | 11.30 |
| 2026-10-29 | LIVN | -5.49 | -0.18 | 11.30 |
| 2026-10-30 | LIVN | -5.49 | -0.18 | 11.30 |
| 2026-11-02 | LIVN | -5.49 | -0.24 | 11.30 |
| 2026-11-03 | LIVN | -5.49 | -0.24 | 11.30 |
| 2026-11-05 | LIVN | -5.49 | -0.24 | 11.30 |
| 2026-11-06 | LIVN | -5.49 | -0.24 | 11.30 |
| 2026-11-09 | LIVN | -5.49 | -0.26 | 11.30 |
| 2026-11-10 | LIVN | -5.49 | -0.26 | 11.30 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
1.03
Avg. EPS Est. Current Quarter
0.97
Avg. EPS Est. Next Quarter
1.06
Insider Transactions
-5.49
Institutional Transactions
-0.26
Beta
0.9
Average Sales Estimate Current Quarter
389
Average Sales Estimate Next Quarter
386
Fair Value
82.01
Quality Score
90
Growth Score
63
Sentiment Score
90
Actual DrawDown %
8.3
Max Drawdown 5-Year %
-63.5
Target Price
108.1
P/E
26.17
Forward P/E
19.27
PEG
1.92
P/S
3.33
P/B
3.66
P/Free Cash Flow
38.91
EPS
3.48
Average EPS Est. Cur. Y
4.43
EPS Next Y. (Est.)
4.72
Target Price Estimates Raised
2
Target Price Estimates Lowered
Profit Margin
13.01
Relative Volume
1.09
Return on Equity vs Sector %
-12
Return on Equity vs Industry %
3.4
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.08
EBIT Estimation
74.1
◆
LIVN
Healthcare
$91.14
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
66.3
Range 1M
64.5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
13.7%
EPS NY
6.7%
52W%
82.2%
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-15.6% upside
Upside
-15.6%
Quality
90
MoS
-10%
LIVN — P/E HistoricalMedical Devices
LivaNova PLCSector: Healthcare
Industry: Medical Devices
Employees: 3300
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.
LIVN
Latest News
—
Caricamento notizie per LIVN…
stock quote shares LIVN – LivaNova PLC Stock Price stock today
news today LIVN – LivaNova PLC stock forecast ,stock prediction 2023 2024 2025
marketwatch LIVN – LivaNova PLC yahoo finance google finance
stock history LIVN – LivaNova PLC invest stock market
stock prices LIVN premarket after hours
ticker LIVN fair value insiders trading